Acridon Tablet

Adult dosage

For adults, take 1 tablet orally once a day. For patients with renal impairment, reduce the dosage or extend the administration interval. Adjust the dosage based on creatinine clearance. 15-35 mL/min/1.73 m²: 50 mg once daily <15 mL/min/1.73 m²: 50 mg every other day Adjust dosage appropriately based on age and symptoms.

This drug should not be used in patients allergic to specific components or sulfonamide drugs. It should also not be administered to patients with very slow heartbeats, heart conduction issues, cardiogenic shock, or very low blood pressure. Patients with metabolic acidosis, severely impaired peripheral blood circulation, dysfunction syndrome, uncontrolled heart failure, and those with anuria should not use this medication. Women who are pregnant or nursing should not be administered this drug, and it is contraindicated for patients with lactose intolerance or specific genetic metabolic disorders as it contains lactose. For heart failure patients, if symptoms are well controlled, it should be used cautiously, and patients with a history of asthma or obstructive airway diseases must consult a physician before taking this medication. Patients with severely impaired liver or kidney function, and those with electrolyte imbalances should also use it with caution. While taking this drug, potassium levels in the blood may decrease, which can affect the heart, so regular check-ups are necessary, especially for patients taking digitalis preparations or elderly patients. Additionally, this drug may affect blood sugar control, so diabetic patients should be cautious, and regular blood glucose testing is recommended for long-term use. This medication can decrease heart rate or lower blood pressure; thus, dosage adjustment may be needed if symptoms of bradycardia or hypotension occur. Patients with hyperthyroidism should exercise caution as this medication may mask symptoms. Abruptly discontinuing this drug may exacerbate symptoms in patients with heart diseases, so gradual withdrawal is safer. Patients with allergic tendencies may experience severe allergic reactions when using this drug, necessitating caution. This medication may interact with various drugs, so if taking other medications, consultation with a physician or pharmacist is essential. It is advisable to avoid this drug during pregnancy or nursing, and if it must be used, nursing should be discontinued. Safety for pediatric patients has not been established, and it is preferable to avoid use in this population. In case of overdose, symptoms such as decreased heart rate, low blood pressure, worsening heart failure, and bronchospasm may occur, requiring immediate medical attention. This medication should be kept out of reach of children and stored in its original container to prevent quality degradation or misuse.

Serious side effects

• Hives
• severe swelling (edema)
• bronchospasm (asthma attack)
• angioedema
• confusion
• headache
• visual disturbances
• hepatotoxicity
• acute heart failure

Mild side effects

• Hyperuricemia
• hypokalemia
• lactose intolerance
• hyponatremia
• bradycardia
• worsening heart failure
• orthostatic hypotension
• chills
• intermittent claudication
• Raynaud's phenomenon

This drug should be stored in a tightly sealed container to protect it from air or moisture, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents deterioration.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle